General Information
Version
2.0
Revision date
2016-08-31
Product name
Methotrexate Injection
Product Synonyms
Methotrexate Injection, USP; Methotrexate Injection (25 mg/ml)
supplier name
Mylan N.V
Emergency telephone
+1 703-741-5970, +1 877-446-3679
Icons in SDS
Company Information
company name
Mylan N.V
e-mail address of the competent person responsible for the Safety Data Sheet
SDScontact@Mylan.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H341, H360
Hazard statements
Code
Statements
H341
Suspected of causing genetic defects
Section 2
SECTION 2: Hazards identification
Classification (GHS-US) Pharmaceutical Agent – Handling of this product in its final form presents minimal occupational exposure risk. Patients/Consumers: Please refer to the product information insert or product label for appropriate consumer-specific information about this product when used according to the physician’s directions. Classification of the Substance or Mixture Classification (GHS-US) Muta. 2 H341 Repr. 1A H360 Label Elements GHS-US labeling
Hazard pictograms
GHS08
Signal word
Danger
Hazard statements
H341 - Suspected of causing genetic defects H360 - May damage fertility or the unborn child
Precautionary statements
P202 - Do not handle until all safety precautions have been read and understood. P280 - Wear eye protection, face protection, protective gloves, protective clothing. P308+P313 - If exposed or concerned: Get medical advice/attention. P405 - Store locked up. P501 - Dispose of contents/container according to local, regional, national, territorial, provincial, and international regulations.
2.1 Classification of the substance or mixture
Classification (GHS-US) Muta. 2 H341
